View the LOSART 50 registration information details.
Back to drug list
ItemsDrug Registration information
ID2077
No2077
Brand NameLOSART 50
IngredientsLOSARTAN POTASSIUM USP 50 MG
Dosage FormTABLET
Primary PackagingALU-PVC BLISTER
Storage
Shelf Life3 YEARD
Pack SizeBOX OF 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsHYPERTENSION : LOSART IS INDICATED FOR THE TREATMENT OF HYPERTENSION. HYPERTENTIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY : LOSART IS INDICATED TO REDUCE THE RISK OF STROKE IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE, ROUND, SEMI BI - CONVEX, FILM - COATED TABLETS ENGRAVED " ACME " ON ONE FACE AND A BREAKLINE ON THE OTHER FACE.
Note
License OwnerPALAMY PHARMA CO., LTD
ManufacturerTHE ACME LABORATORIES LTD.
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 I 4218/17
FDD Registration Date19/05/2023
Expiry Date18/05/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA